Managers / Q3 2023 · view latest →
HARBOURVEST PARTNERS LLC
CIK 0001201001 · ONE LINCOLN STREET, SUITE 1700, BOSTON, MA, 02111 · 617-348-3707
Reported Value
$295M
Q3 2023
Positions
58
Filings on Record
32
2019–present window
Filed
Nov 14, 2023
original filing
Summary
Harbourvest Partners LLC reported $295M in U.S.-listed holdings across 58 positions for Q3 2023.
The portfolio is heavily concentrated: W alone accounts for 21.8% of reported value.
Compared with Q2 2023, the fund opened 6 new positions and exited 8.
Portfolio Metrics
Turnover
+5.2%
vs prior filed quarter
Top-10 Concentration
+81.2%
share of reported value
Largest Position
+21.8%
Wayfair
New / Exited
6 / 8
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 78.4% · $231M
- Other · 17.3% · $51M
- ADR · 4.3% · $13M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CXMSprinklr, Inc | NEW | +220.5K | 220.5K | +$3M | $3M |
| Axcella Health, Inc. | NEW | +248.3K | 248.3K | +$3M | $3M |
| SONDQSonder Holdings, Inc. | NEW | +225.1K | 225.1K | +$2M | $2M |
| SANASana Biotechnology, Inc. | NEW | +137.7K | 137.7K | +$532,876 | $532,876 |
| Nano-X Imaging Ltd. | NEW | +3.7K | 3.7K | +$24,128 | $24,128 |
| Astra Space, Inc. | NEW | +12.4K | 12.4K | +$23,021 | $23,021 |
| EVLOEvelo Biosciences, Inc. | ADDED | +1.30M | 1.45M | +$5M | $6M |
| QSQuantumScape Corporation | ADDED | +42.5K | 71.5K | +$247,010 | $478,328 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2023
58 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | WWayfair Inc.history → | Common CLA | 21.84% | $64M | 1.06M |
| 2 | TOSTToast, Inc.history → | Common CLA | 14.52% | $43M | 2.28M |
| 3 | NABLN-Able, Inc.history → | Common | 13.72% | $40M | 3.13M |
| 4 | Solarwinds Corp. | Common | 9.97% | $29M | 3.11M |
| 5 | monday.com Ltd. | SHS | 9.84% | $29M | 182.0K |
| 6 | Omega Therapeutics, Inc. | Common | 2.56% | $8M | 3.51M |
| 7 | Hammerhead Energy Inc. | Common CLA | 2.46% | $7M | 607.3K |
| 8 | YMMFull Truck Alliance Co. Ltd.history → | Sponsored ADS | 2.29% | $7M | 957.6K |
| 9 | HSAIHesai Grouphistory → | Sponsored ADS | 2.06% | $6M | 606.1K |
| 10 | EVLOEvelo Biosciences, Inc.history → | Common | 1.93% | $6M | 1.45M |
| 11 | HCP2EURHashiCorp, Inc.history → | Common CLA | 1.62% | $5M | 209.3K |
| 12 | LCEURLendingClub Corp.history → | Common | 1.06% | $3M | 513.4K |
| 13 | CXMSprinklr, Inchistory → | Common CLA | 1.04% | $3M | 220.5K |
| 14 | PGNYProgyny, Inc.history → | Common | 1.04% | $3M | 89.7K |
| 15 | Spotify Technology S.A. | SHS | 0.88% | $3M | 16.8K |
| 16 | Axcella Health, Inc. | Common New | 0.88% | $3M | 248.3K |
| 17 | Inari Medical | Common | 0.86% | $3M | 38.5K |
| 18 | RLAYRelay Therapeutics, Inc. | Common | 0.85% | $2M | 296.4K |
| 19 | ACVAACV Auctions, Inc. | Common CLA | 0.76% | $2M | 147.1K |
| 20 | BEBloom Energy Corporation | Common CLA | 0.73% | $2M | 162.2K |
| 21 | OLOGBXOlo, Inc. | Common CLA | 0.70% | $2M | 341.8K |
| 22 | COURCoursera, Inc. | Common | 0.67% | $2M | 106.1K |
| 23 | SONDQSonder Holdings, Inc. | CL A NEW | 0.63% | $2M | 225.1K |
| 24 | AMPLAmplitude Inc. | Common CLA | 0.60% | $2M | 153.0K |
| 25 | Jfrog Ltd. | ORD SHS | 0.51% | $1M | 59.0K |
| 26 | ZUOUSDZuora, Inc. | Common | 0.46% | $1M | 163.9K |
| 27 | PATHUiPath, Inc. | Common CLA | 0.45% | $1M | 76.9K |
| 28 | IASIntegral Ad Science, Inc. | Common | 0.37% | $1M | 91.8K |
| 29 | UUnity Software | Common | 0.36% | $1M | 34.2K |
| 30 | DOCNDigital Ocean, Inc. | Common | 0.36% | $1M | 44.2K |
| 31 | DOCSDoximity, Inc. | Common CLA | 0.36% | $1M | 49.8K |
| 32 | EB4Eventbrite, Inc. | Common CLA | 0.34% | $1M | 102.2K |
| 33 | FTCHQFarfetch Ltd. | Ordinary Shares CLA | 0.31% | $925,276 | 442.7K |
| 34 | PLRXPliant Therapeutics, Inc. | Common | 0.29% | $857,186 | 49.4K |
| 35 | TWLOTwilio, Inc. | Common CLA | 0.29% | $852,899 | 14.6K |
| 36 | DIBS1stdibs.com, Inc. | Common | 0.25% | $726,165 | 199.5K |
| 37 | GTMZoom Information, Inc | Common | 0.22% | $634,565 | 38.7K |
| 38 | HNSTThe Honest Company Inc. | Common | 0.20% | $599,293 | 475.6K |
| 39 | AFRMAffirm, Inc. | Common CLA | 0.20% | $587,243 | 27.6K |
| 40 | PINSPinterest, Inc. | Common CLA | 0.20% | $576,009 | 21.3K |
| 41 | IBRXImmunityBio, Inc. | Common | 0.19% | $567,348 | 335.7K |
| 42 | SANASana Biotechnology, Inc. | Common | 0.18% | $532,876 | 137.7K |
| 43 | HOODRobinhood Markets Inc. | Common CLA | 0.17% | $497,220 | 50.7K |
| 44 | QSQuantumScape Corporation | Common CLA | 0.16% | $478,328 | 71.5K |
| 45 | CPNGCoupang Inc. | Common CLA | 0.15% | $456,178 | 26.8K |
| 46 | Bright Health Group, Inc. | Common | 0.11% | $314,738 | 52.7K |
| 47 | DASHDoorDash, Inc. | Common CLA | 0.07% | $199,072 | 2.5K |
| 48 | PACBPacific Biosciences of California, Inc. | Common | 0.07% | $196,091 | 23.5K |
| 49 | RPTXRepare Therapeutics, Inc. | Common | 0.05% | $148,294 | 12.3K |
| 50 | OPENOpendoor Technologies Inc. | Common | 0.04% | $123,306 | 46.7K |
| 51 | MCRB1EURSeres Therapeutics, Inc. | Common | 0.04% | $117,484 | 49.4K |
| 52 | Rallybio Holdings, LLC | Common | 0.03% | $73,725 | 21.9K |
| 53 | PMVPPMV Pharmaceuticals | Common | 0.02% | $70,813 | 11.5K |
| 54 | IPSCCentury Therapeutics, Inc. | Common | 0.02% | $58,036 | 29.0K |
| 55 | Nano-X Imaging Ltd. | Ordinary Shares CLA | 0.01% | $24,128 | 3.7K |
| 56 | Astra Space, Inc. | CL A NEW | 0.01% | $23,021 | 12.4K |
| 57 | Aligos Therapeutics, Inc. | Common | 0.00% | $14,031 | 18.8K |
| 58 | NXTCEURNextCure, Inc. | Common | 0.00% | $12,957 | 10.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $101M | 5 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $174M | 7 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $205M | 9 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $91M | 15 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $154M | 16 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $203M | 22 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $192M | 34 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $188M | 40 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $219M | 48 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $299M | 53 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $295M | 58 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $352M | 60 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $297M | 63 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $299M | 65 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $306M | 67 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $305M | 62 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $490M | 66 | May 26, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2021 | $782M | 67 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.1B | 56 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.0B | 51 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $746M | 44 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $256M | 26 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $270M | 36 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $232M | 28 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $207M | 36 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $243M | 35 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $240M | 33 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $262M | 32 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $283M | 33 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $211M | 32 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.